Diagnosis of Zollinger-Ellison syndrome. From symptoms to biological evidence

Italian Journal of Gastroenterology and Hepatology

Volumn 31, Issue 7 SUPPL. 2, 1999, Pages

  Cadiot, G ^a   Jais P ^a   Mignon, M ^a  

^a BICHAT HOSPITAL   (France)

Author keywords

Gastric acid; Multiple endocrine neoplasia type 1; Primary hyperparathyroidism; Secretin test; Zollinger Ellison syndrome

Indexed keywords

CALCIUM; CHROMOGRANIN A; GASTRIN; PROGASTRIN; SECRETIN;

CLINICAL FEATURE; CONFERENCE PAPER; DIAGNOSTIC TEST; GASTRIN BLOOD LEVEL; HUMAN; INSULINOMA; MULTIPLE ENDOCRINE NEOPLASIA; PROVOCATION TEST; STOMACH ACID SECRETION; ZOLLINGER ELLISON SYNDROME;

AGE OF ONSET; DIAGNOSIS, DIFFERENTIAL; FEMALE; GASTRIC ACID; GASTRINS; HUMANS; MALE; MIDDLE AGED; MULTIPLE ENDOCRINE NEOPLASIA TYPE 1; PROGNOSIS; ZOLLINGER-ELLISON SYNDROME;

EID: 0032703516     PISSN: 11258055     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Mignon M, Bonfils S. Diagnosis and treatment of Zollinger-Ellison syndrome. In: Piper DW, editor. Peptic ulcer. Bailliere's Clin Gastroenterol 1988;2:677-98.
2. Jensen RT, Gardner JD. Gastrinoma. In: Go VLW, Gardner JD, Brooks FP, DiMagno E, Lebenthal E, Scheele GS, editors. The pancreas: biology, pathobiology, and disease. 2nd edition. New York: Raven Press; 1993. p. 931-78.
3. Weber HC, Venzon DJ, Lin J-T, Fishbein VA, Orbuch M, Dtrader DB, et al. Determinants of metastatic rate and survival in patients with Zollinger-Ellison syndrome: a prospective long-term study. Gastroenterology 1995;108:1637-49.
4. Cadiot G, Lebtahi R, Sarda L, Bonnaud G, Marmuse JP, Vissuzaine C, et al. Preoperative detection of duodenal gastrinomas and peripancreatic lymph nodes by somatostatin receptor scintigraphy. Gastroenterology 1996;111:845-54.
5. Mignon M, Jaïs P, Cadiot G, Vatier J. Clinical features and advances in biological diagnostic criteria for Zollinger-Ellison syndrome. In: Mignon M, Jensen RT, editors. Endocrine tumors of the pancreas: recent advances in research and management. Basel: Karger Publishers; Front Gastrointest Res 1995;23:223-9.
6. Weber HC, Venzon DJ, Jensen RT, Metz DC. Studies on the interrelation between Zollinger-Ellison syndrome, Helicobacter pylori, and proton pump inhibitor therapy. Gastroenterology 1997;112:84-91.
7. Maton PN. The management of Zollinger-Ellison syndrome: a review article. Aliment Pharmacol Ther 1993;7:467-75.
8. Rambaud JC, Matuchansky C. Diarrhea and digestive endocrine tumours. Clin Gastroenterol 1974;3:657-70.
9. Miller LS, Vinayek R, Frucht H, Gardner JD, Jensen R, Maton PN. Reflux esophagitis in patients with Zollinger-Ellison syndrome. Gastroenterology 1990;98:341-6.
10. Cadiot G, Hélié C, Vallot T, Marmuse JP, Cosnes J, Riché A, et al. Oesophagite sténosante au cours du syndrome de Zollinger-Ellison. Gastroenterol Clin Biol 1994;18:1018-20.
11. Mignon M, Cadiot G, Rigaud D, Ruszniewski Ph, Jaïs P, Lehy T, et al. Management of islet cell tumors in patients with multiple endocrine neoplasia type 1. In: Mignon M, Jensen RT, editors. Endocrine tumors of the pancreas. Recent advances in research and management. Basel: Karger; Front Gastrointest Res 1995;23:342-59.
12. Chanson P, Cadiot G, Murat A, GENEM 1. Management of patients and subjects at risk for multiple endocrine neoplasia type 1: MEN 1. Horm Res 1997;47:211-20.
13. Notar-Francesco V, Samuel S, Kanakamedala S, Strauss E. Commercial laboratories do not measure serum gastrin accurately or precisely. Gastroenterology 1993;104:A160.
14. Jaïs P, Mignon M. Normal serum gastrin concentration in gastrinoma. Lancet 1995;346:1421-2.
15. Zimmer T, Stölzel U, Bäder M, Fett U, Foss HD, Riecken EO, et al. A duodenal gastrinoma in a patient with diarrhoea and normal serum gastrin concentrations. N Engl J Med 1995;333:634-6.
16. Frucht H, Howard JM, Slaff JI, Wank SA, McCarthy DM, Maton PN, et al. Secretin and calcium provocative tests in the Zollinger-Ellison-syndrome. A prospective study. Ann Intern Med 1989;111:713-22.
17. Frucht H, Howard JM, Stark HA, McCarthy DM, Maton PN, Gardner JD, et al. Prospective study of the standard meal provocative test in Zollinger-Ellison syndrome. Am J Med 1989;87:528-36.
18. Mignon M, Rigaud D, Cambray S, Chayvialle JA, Accary JP, René E, et al. A comparative evaluation of secretin bolus and secretin infusion as secretin provocation tests in the Zollinger-Ellison syndrome. Scand J Gastroenterol 1985;20:791-7.
19. Isenberg JI, Walsh JH, Passaro EJR, Moore EW, Grossman MI. Unusual effect of secretin on serum gastrin, serum calcium and gastric acid secretion in a patient with suspected Zollinger-Elison syndrome. Gastroenterology 1972;62:626-31.
20. Poynard T, Mignon M, Accary JP, Bonfils S. Sensitivity, specificity and predictive value of the secretin infusion test in the diagnosis of gastrinoma. Gastroenterol Clin Biol 1986;10:492-6.
21. McArthur KE, Collen MJ, Maton PN, Chemer JA, Howard JM, Ciarleglio CA, et al. Omeprazole: effective, convenient therapy for Zollinger-Ellison syndrome. Gastroenterology 1985;88:939-44.
22. Vallot T, Mignon M, Mazure R, Bonfils S. Evaluation of antisecretory drug therapy of Zollinger-Ellison syndrome using 24-hour pH monitoring. Dig Dis Sci 1983;28:577-84.
23. Rehfeld JF, Bardram L. Prohormone processing and pancreatic endocrine tumors. In: Mignon M, Jensen RT, editors. Endocrine tumors of the pancreas. Recent advances in research and management. Basel: Karger; Front Gastrointest Res 1995;23:84-98.
24. Cadiot G, Mouillier P, Allouch A, Paillard M, Mignon M, GRESZE. Interest of the oral calcium tolerance test in the early diagnosis of primary hyperparathyroidism and multiple endocrine neoplasia type 1 in patients with the Zollinger-Ellison syndrome. Gut 1996;39:273-8.